One hundred and fifty two Chinese patients with myasthenia gravis in Taiwan were investigated for HLA-A, B, C and DRIDQ typing. HLA-Bw46 and DR9 frequencies were significantly increased in patients compared with the control group, and there was a decrease in DR3. Further analysis between different subgroups of patients showed Bw46 and DR9 were more significantly increased in the juvenile group than in the adult group. No single HLA allele was associated with either clinical type or thymic pathology, but there was an excess of BW46DR9 combination in both juvenile and ocular type patients. The Chinese population with myasthenia gravis is characterised by earlier age at onset, more ocular forms and less clinically severe illness than in whites, and these characteristics indicate a special subgroup that correlates with the strong Bw46DR9 association.
Myasthenia gravis is a well recognised autoimmune disease which affects neuromuscular junctions. The aberrant immune response is believed in part to be caused by genetic factors. Two lines of research have associated disease susceptibility to human genes, that is, immunoglobulin allotypes' and human leukocyte antigens (HLA). The associations between myasthenia gravis and HLA antigens have been discussed frequently and show interesting ethnic differences: HLA-B8 and DR3 in whites,2 Al, B8 and DR5 in American blacks,3 DR9 and DRw8 in Japanese4 and Bw46 and DR9 in Chinese. [5] [6] [7] [8] [9] Furthermore the disease is heterogeneous with different HLA associations in different subgroups of patients; for example, in whites A3, B7 The association of Bw46 and DR9 with myasthenia gravis was strongest before age 20 and declined thereafter (fig 1) , so that patients with either Bw46 or DR9 were significantly younger than those without. The mean age at onset in patients positive and negative for Bw46 was: 20-7 v 29-0, t = -3-59, p < 0-001; mean age at onset in patients positive and negative for DR9 was: 23-3 v 29-0, t = -2-24, p = 0-02. The associations seemed to result from the Bw46DR9 combination (mean age at onset: 18-7) as neither Bw46 nor DR9 alone was associated with younger age of onset after removing the Bw46DR9 combination from the calculation (table 3) .
No association between thymic pathology and HLA was noted. Even in the thymoma group which was represented by older age of onset, however, those with Bw46 were still younger than those without. Mean age at onset in patients with thymoma positive and negative for Bw46 was: 25-7 v 44 9, t = 2-87, The age at onset, among other variables determining the subgroups of myasthenia gravis, is most significant in relation to HLA differences. In the present study, the association is mainly in the juvenile group as in all Table 3 Analysis of age at onset (years) in association with HLA-Bw46 and DR9.
Bw46 ( previous reports from studies on Chinese. In whites, the age at onset is also an important determinant in correlating HLA frequencies and in subclassifying the disease: Al, B8 and DR3 are associated with onset age below 40 and A3, B7 and DR2 are associated with onset age over 40.2 Similar findings are noted in Japanese. Matsuki et al 17 described a strong association of DR9, DRwl3 and DQw3 and the association was strongest before three years of age and decreased thereafter. It is noteworthy that a few other autoimmune diseases share such age dependent difference and HLA association, notably insulin-dependent diabetes with B8DR3 or B15DR4'8 and juvenile rheumatoid arthritis with B27 or DR5.'9 Both diseases are clearly distinct form their adult counterparts.
There is a major difference in the age-incidence of myasthenia gravis between whites and Chinese populations; in the Chinese, the disease often has an earlier onset and runs a more benign course with mainly ocular involvement. Whether this subgroup represents a separate entity or is merely an early presentation of the continuing spectrum of the disease is an issue of interest. In our study it is with this particular subgroup that Bw46DR9 is most closely associated, perhaps suggesting that the underlying immunopathogenesis differs in these subgroups. It can also be inferred that the differences of clinical manifestations between Chinese and white patients with myasthenia are immunogenetically based.
The Japanese population with myasthenia, on the other hand, resembles the Chinese in the large number of patients with juvenile and ocular myasthenia. In earlier studies of HLA associations in Japanese patients, the results were inconsistent and the associations often weak. Typing for DR9 has recently given more consistent results. Kida et al4 pointed out that DR9 was associated with ocular myasthenia gravis whereas DRw8 was associated with generalised disease. Although they did not specify the associations with age at onset, patients with their ocular myasthenia are clearly younger than those with gener- '7 showed that the frequencies of DR9 and DRw13 were significantly increased in patients below three years of age. DR9 consistently showed the strongest association in juvenile Japanese patients, as in the Chinese. Interestingly, the Bw46DR9 haplotype was significantly increased in the Matsuki series, although it was only seen in five of 31 DR9 positive patients. The close relationship between Chinese and Japanese patient populations may suggest a common genetic background (table 4) .
We do not have enough data on acetylcholine receptor antibody titre to be included in the present study and are therefore unable to discuss the association between HLA and This study was supported by grants from the National Science Council, Republic of China (NSC 77-0412-B002-50).
